focus
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: Beware reading your test results before your doctor does
Next article: Beware reading your test results before your doctor does
leisure time
hotspot
-
Security flaws in third
2025-09-30 14:35 -
In same hospitals, Black patients receive fewer opioids than white patients
2025-09-30 14:07 -
Amylyx's ALS drug launch starts strong. It could be trouble for FDA
2025-09-30 13:42 -
Why failed clinical trials don’t always spell doom for a new drug
2025-09-30 13:41 -
Lupron, used to halt puberty in children, may cause lasting health problems
2025-09-30 13:04 -
Fatty liver disease was alleviated by Lilly’s ‘triple
2025-09-30 12:45